| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6159593 | The Journal of Urology | 2011 | 7 Pages |
Abstract
Adding androgen deprivation therapy to definitive radiotherapy does not significantly impact the time to return to baseline health related quality of life. These data may be valuable for patients and physicians when weighing the toxicity and benefits of androgen deprivation therapy when added to definitive radiotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jonathan D. Grant, Mark S. Litwin, Lorna Kwan, Steve P. Lee, Michael L. Steinberg, Christopher R. King,